Research Laboratory of the Dept. of Internal Medicine B at @UK_Muenster and @uni_muenster.
Tweets represent personal views from lab members and @JonelTrebicka.
Does more time on albumin before terlipressin change response? In 145 patients treated for suspected HRS-AKI, a retrospective study found no detectable difference between <24 h and 24–60 h. The study leaves the optimal timing open.
https://t.co/AEJWF1RD03
Could acute abdominal pain and neurological symptoms be connected? That’s one question on today’s UKM Rare Diseases Symposium programme, alongside a talk on IgA nephropathy. @MPraktiknjo and @JonelTrebicka will open the event.
A look back at our September research retreat. Away from the bench and clinic, we had time to hear what colleagues across MedB Lab are working on and discuss the questions that connect our work. Thanks to everyone who took part and helped organise it.
In a retrospective cohort of 142 neutropenic patients with Pseudomonas bloodstream infection, approximately one in five had skin involvement.
With contributions from MedB colleagues. Published in Clinical Microbiology and Infection.
https://t.co/NZl3wTyHzE
Beyond COVID: baseline data from 1,257 participants across six German cities highlight persistent fatigue, concentration difficulties and breathlessness.
With Julia Fischer & Phil-Robin Tepasse. Findings describe this cohort.
https://t.co/gPE3kr44PL
The mouth–gut connection in cirrhosis: an iMeta paper combines metagenomics and modelling to link oral–gut microbial overlap with altered metabolic profiles.
Predicted ammonia and acetate production offers a direction for further research.
https://t.co/i37rwlUbBC
In a prospective cirrhosis cohort, cumulative antibiotic exposure was associated with newly detected multidrug-resistant organisms, which were also linked to higher mortality.
With Kai-Henrik Peiffer & @JonelTrebicka .
https://t.co/A2a0ATvPo4
A Münster study of 181 ulcerative colitis patients linked CMV-positive biopsies with higher disease activity and lower remission rates. No significant association with colectomy was found.
Retrospective findings; causality remains unclear.
https://t.co/OlgctHIEw6
How does the liver adapt to long-term metabolic stress?
A Science Advances study highlights CPEB4-dependent regulation as part of the liver’s response to chronic stress in MASLD/MASH.
With @JonelTrebicka , @R_Schierwagen & Maximilian Brol among the authors.
#MASLD#Hepatology
Greetings from #Viszeralmedizin26 in Hamburg 🇩🇪
This year’s theme: Prevention, Translation and Perspectives.
A great opportunity to exchange ideas, discuss new research and strengthen collaboration across gastroenterology and hepatology.
#DGVS#Hepatology#Gastroenterology
New publication in Nature Reviews Gastroenterology & Hepatology.
An international Delphi consensus provides 15 recommendations for standardizing clinical microbiome studies, covering metadata, sample collection, and clinical end points.
Read here:
🔗 https://t.co/dru9lla8CT
Publication Highlight 📄
Endohepatology is expanding the role of endoscopy in liver disease.
Prof. @JonelTrebicka , Dr. @MPraktiknjo and colleagues review the latest advances in the American Journal of Gastroenterology.
🔗 https://t.co/s58Glfs2wY
Improving outcomes in HCC begins with earlier detection.
Current surveillance remains the standard of care, while novel biomarkers and AI-based risk stratification continue to evolve through clinical research.
Read the latest AGA Clinical Practice Update: https://t.co/aHeuyTTkVY
Why do outcomes differ in advanced cirrhosis?
New research with contribution from our team and @JonelTrebicka used blood multiomics to identify a dysregulated lipid mediator–mitochondrial network associated with patient outcomes.
📄 Read the study: https://t.co/xTLZC9sQsO
Can AI support clinical decision-making in liver cancer?
Our latest study evaluates GPT models in hepatocellular carcinoma.
The findings show AI's potential as a clinical decision-support tool while reinforcing that expert oversight remains essential.
https://t.co/urPI3rTNSQ
Many liver diseases remain undetected for years.
This week, the European Liver Screening Tour brought free, non-invasive liver screening directly to Münster.
🧡 Early detection matters.
#LiverHealth#Prevention#Hepatology
🧡 Free liver screening in Münster!
A quick, painless and non-invasive check can help identify early signs of liver disease.
📍 Stubengasse | 9–10 June | 10:00–19:00
📍 UKM A9 | 11 June | 10:00–13:00
📍 Gievenbeck Market | 11 June | 14:00–18:00
No appointment needed.
#Münster
Strong presence from MedB at #EASLCongress2026 in Barcelona.
Great to see our clinicians and young investigators presenting and discussing current research in hepatology, cirrhosis and liver disease throughout this week’s congress.
#EASL#Hepatology#LiverDisease
MedB explains: Portal Hypertension
What it actually means:
Blood can’t flow properly through the liver, so pressure builds up in surrounding vessels.
Why it matters:
This silent pressure is what triggers many of the most dangerous liver complications.